TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection

STAT1 Coronavirus
DOI: 10.1126/sciadv.abi6802 Publication Date: 2021-12-08T18:55:18Z
ABSTRACT
Limited understanding of T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has impeded vaccine development and drug discovery for disease 2019 (COVID-19). We found that triggering receptor expressed on myeloid cells (TREM-2) was induced in the blood lungs patients with COVID-19. After binding to SARS-CoV-2 membrane (M) protein through its immunoglobulin domain, TREM-2 then activated CD3ζ/ZAP70 complex, leading STAT1 phosphorylation T-bet transcription. In vitro stimulation M protein-reconstituted pseudovirus or recombinant protein, promoted helper 1 (TH1) cytokines interferon-γ tumor necrosis factor. vivo infection CD4–TREM-2 conditional knockout mice murine mouse hepatitis virus A-59 showed intrinsic enhanced TH1 response viral clearance, thus aggravating lung destruction. These findings demonstrate a previously unidentified role infection, suggest potential strategies clinical management
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (73)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....